ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

Funding Opportunities

January 10, 2003

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike

February 8, 1974